Evaluation of intraoperative slow-release dexamethasone implant combined with idiopathic epiretinal membrane removal.
Alfonso SavastanoAlice BitossiFabrizio GiansantiLorenzo VannozziTomaso CaporossiFrancesco BarcaGianni VirgiliGloria GambiniUmberto De VicoPatrizio BernardinelliMaria Cristina SavastanoStanislao RizzoPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2020)
In this study, DEX accelerated the improvement of BCVA at 15 days after surgery. However, no evidence of further anatomical (CMT) and functional (BCVA) DEX effectiveness combined with removal of idiopathic ERM by 25-G PPV at 30 and 90 days follow-up was observed.